A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval
According to a story from Market Screener, the drug company AbbVie recently announced that its investigational therapy epcoritamab has received a positive opinion from the European Union's Committee for Medicinal…